Indium-111-bleomycin complex in squamous cell cancer xenograft tumors of nude mice

Cancer Biotherapy and Radiopharmaceuticals

Volumn 20, Issue 4, 2005, Pages 426-435

  Jääskelä Saari, Hilkka A ^a   Grénman, Reidar ^b   Ramsay, Hans A ^a   Tarkkanen, Jussi ^c   Paavonen, Timo ^d   Kairemo, Kalevi J A ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF OULU   (Finland)

Author keywords

111InBLMC; Bleomycin; Squamous cell cancer cell lines; Xenograft

Indexed keywords

BLEOMYCIN; BLEOMYCIN IN 111; KI 67 ANTIGEN; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; CYTOTOXICITY; DNA DETERMINATION; FLOW CYTOMETRY; HEAD AND NECK CANCER; MALE; MITOSIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; SCINTILLATION CAMERA; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BLEOMYCIN; BODY WEIGHT; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COMBINED MODALITY THERAPY; DNA; FLOW CYTOMETRY; GAMMA CAMERAS; HYDROGEN-ION CONCENTRATION; INDIUM RADIOISOTOPES; KI-67 ANTIGEN; MICE; MICE, NUDE; MITOSIS; MODELS, CHEMICAL; NEOPLASM TRANSPLANTATION; RADIOPHARMACEUTICALS; TIME FACTORS;

EID: 24044541049     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2005.20.426     Document Type: Article

References (33)

1. Munro AJ. An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer. Br J Cancer 1995;71:83.
2. Bourhis J, Eschwege F. Radiotherapy-chemotherapy combinations in head and neck squamous cell carcinoma: Overview of randomized trials. Anticancer Res 1996;16:2397.
3. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: Three meta-analyses of updated individual data. Lancet 2000;355:949.
4. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003; 349:2091.
5. Bernier J, Doamenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945.
6. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck. N Engl J Med 2004;350:1937.
7. Umezawa H, Suhara Y, Takita T, et al. New antibiotics, bleomycin A and B. J Antibiot (A) 1966;19:200.
8. Kuo MT, Haidle CW. Characterization of chain breakage in DNA induced by bleomycin. Biochem Biophys Acta 1973;335:109.
9. Barranco SC, Humphrey RM. The effects of bleomycin on survival and cell progression in Chinese hamster cells in vitro. Cancer Res 1971;31:1218.
10. Urade M, Ogura T, Mima T, et al. Establishment of human squamous carcinoma cell lines highly and minimally sensitive to bleomycin and analysis of factors involved in the sensitivity. Cancer 1992;69:2589.
11. Jääskelä-Saari HA, Kairemo KJA, Jekunen AP, et al. Cytotoxicity of bleomycin and external radiation in squamous cell cancer cell lines of head and neck. Cancer Detect Prevent 1996;20:279.
12. Grénman R, Burk D, Virolainen E, et al. Radiosensitivity of head and neck cancer cells in vitro. Arch Otolaryngol Head Neck Surg 1988;114:427.
13. Grénman R, Carey TE, McClatchey KD, et al. In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck. Cancer 1991;67:2741.
14. Elprana D, Kuijpers W, Wessels JMC, et al. Chemosensitivity testing of xenografted squamous cell carcinomas of the head and neck region. Anticancer Res 1992; 12:2229.
15. Wahlberg P, Wennerberg J, Aim P, et al. The effect of continuous bleomycin infusion on the growth and cell kinetics of heterotransplanted squamous cell carcinoma of the head and neck. Anticancer Res 1987;7:55.
16. Sastry KSR, Rao DV. Dosimetry of low-energy electrons. In: Rao DV, Chandra R, Graham M, eds., Physics of Nuclear Medicine: Recent Advances. New York: American Institute of Physics, 1984:169.
17. Howell RW. Radiation spectra for Auger-electron-emitting radionuclides: Report no. 2 of AAPM Nuclear Medicine Task Group no. 6. Med Phys 1992;19: 1371.
18. Hou DY, Hoch H, Johnston GS, et al. A new In-111-bleomycin complex for tumor imaging: Preparation, stability, and distribution in glioma-bearing mice. J Surg One 1984;25:168.
19. Hou DY, Maruyama Y. Distribution of In-111-bleomycin complex in small-cell lung cancer cells by autoradiography. J Surg Oncol 1992;49:93.
20. Jääskelä-Saari HA, Kairemo KJA, Ramsay HA. Labeling of bleomycin with Auger-emitter increases cytotoxicity in squamous cell cancer cell lines, Int J Radiat Biol 1998;73:565.
21. 111Inbleomycin complex for combined radiotherapy and chemotherapy. J Surg Oncol 1985;29:91.
22. Kairemo KJA, Ramsay HA, Tagesson M, et al. Indium-111 bleomycin complex for radiochemotherapy of head and neck cancer-dosimetric and biokinetic aspects. Eur J Nucl Med 1996;23:631.
23. 111In-labeled bleomycin complex for the differentation of high- and low-grade gliomas. Nucl Med Commun 1999;20:145.
24. Lansford CD, Grénman R, Bier H, et al. Head and neck cancers. In: Masters J, Palsson B, eds., Human Cell Culture Vol 2, Cancer Cell Lines Part 2. Dordrecht (Holland): Kluwer Academic Press, 1999:185.
25. Kairemo KJA, Ramsay HA, Paavonen T, et al. Imaging and staging of head and neck cancer using a low pH In-111-bleomycin complex. Eur J Cancer 1996; 32B:311.
26. Hsu SM, Raine L, Fanger, H. Use of the avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577.
27. Alanen K, Klemi PJ, Taimela S, et al. A simple preservative for flow cytometric DNA analysis. Cytometry 1989;10:86.
28. Sham E, Durand RE. Cell kinetics and repopulation parameters of irradiated xenograft tumours in SCID mice: Comparison of two dose-fractionation regimens. Eur J Cancer 1999;35:850.
29. Elomaa L, Joensuu H, Kulmala J, et al. Squamous cell carcinoma is highly sensitive to Taxol, a possible new radiation sensitizer. Acta Otolaryngol 1995;115:340.
30. Sinclair WK. Cyclic X-ray responses in mammalian cells in vitro. Radiat Res 1978;33:620.
31. 191Pt) on nude mice. Int J Radiat Oncol Biol Phys 2001;49:827.
32. l86Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts. Cancer Res 1993;53:3524.
33. 186Re in human ovarian cancer xenografts. Int J Radiat Oncol Phys 1997;38:813.